Product Code: ETC13340942 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global mRNA Vaccines and Therapeutics Market was valued at USD 30 Billion in 2024 and is expected to reach USD 43.53 Billion by 2031, growing at a compound annual growth rate of 5.60% during the forecast period (2025-2031).
The Global mRNA Vaccines and Therapeutics Market is experiencing significant growth driven by the success of mRNA technology in combating infectious diseases and cancer. The market is expected to expand rapidly due to the development of mRNA-based COVID-19 vaccines by companies like Pfizer-BioNTech and Moderna. Factors such as increasing investment in research and development, rising prevalence of chronic diseases, and advancements in biotechnology are fueling the market growth. Additionally, the potential of mRNA technology in personalized medicine and the ability to rapidly produce vaccines for emerging infectious diseases are further driving market expansion. However, challenges such as high production costs and the need for cold-chain storage may hinder the market`s growth to some extent. Overall, the Global mRNA Vaccines and Therapeutics Market is poised for continued growth and innovation in the coming years.
The Global mRNA Vaccines and Therapeutics market is experiencing significant growth driven by the success of mRNA-based COVID-19 vaccines and increasing investments in research and development. Key trends include the expansion of mRNA technology beyond infectious diseases to cancer immunotherapy and rare diseases, as well as the potential for personalized medicine applications. Opportunities in the market lie in partnerships between pharmaceutical companies and biotech firms to accelerate product development, advancements in delivery systems to enhance efficacy and safety of mRNA therapeutics, and the potential for mRNA vaccines to address emerging infectious diseases. Regulatory approvals and increasing public acceptance of mRNA technology further support the market`s growth trajectory.
The Global mRNA Vaccines and Therapeutics Market faces several challenges, including manufacturing complexities due to the need for specialized equipment and processes, storage and distribution requirements such as cold chain logistics, regulatory hurdles related to the novelty of mRNA technology, potential side effects and safety concerns that may impact public acceptance, and competition from traditional vaccines and other emerging technologies. Additionally, the high cost of mRNA vaccines and therapeutics compared to conventional options poses a barrier to widespread adoption, especially in developing regions. Ensuring scalability to meet global demand, addressing supply chain vulnerabilities, and building trust in the efficacy and safety of mRNA-based products are key challenges that industry players need to navigate for the successful growth of this market.
The Global mRNA Vaccines and Therapeutics Market is primarily driven by factors such as the increasing prevalence of infectious diseases, growing focus on personalized medicine, advancements in mRNA technology, and the effectiveness of mRNA vaccines in providing rapid immune responses. Additionally, the ongoing COVID-19 pandemic has accelerated the demand for mRNA-based vaccines, further propelling market growth. The potential of mRNA technology to revolutionize the treatment of various diseases, including cancer and rare genetic disorders, is also a key driver driving investment and research in this market. Moreover, collaborations between pharmaceutical companies and research institutions to develop novel mRNA therapies and vaccines are contributing to the overall expansion of the market.
Government policies related to the Global mRNA Vaccines and Therapeutics Market are primarily focused on accelerating the development and distribution of mRNA-based vaccines and therapeutics to combat diseases like COVID-19. Governments worldwide have allocated substantial funding for research, development, and manufacturing of mRNA-based products, along with streamlining regulatory processes to expedite approvals. Initiatives such as Operation Warp Speed in the United States and the European Union`s Advanced Purchase Agreements have played a crucial role in supporting companies in this market. Additionally, governments are actively engaging in partnerships with pharmaceutical companies to ensure equitable access to mRNA vaccines globally, with initiatives like COVAX aiming to provide vaccines to low- and middle-income countries. Overall, government policies are geared towards promoting innovation, production capacity, and accessibility of mRNA vaccines and therapeutics on a global scale.
The Global mRNA Vaccines and Therapeutics Market is expected to experience significant growth in the coming years due to the success of mRNA technology in developing effective COVID-19 vaccines. The market is projected to expand rapidly as more companies invest in mRNA research for various infectious diseases, cancer treatments, and rare genetic disorders. The increasing acceptance of mRNA technology, its ability to trigger a robust immune response, and its potential for rapid vaccine development are driving the market forward. Additionally, ongoing advancements in mRNA delivery systems and manufacturing processes will further propel market growth. Overall, the Global mRNA Vaccines and Therapeutics Market is poised for substantial expansion and innovation in the foreseeable future.
In the global mRNA vaccines and therapeutics market, North America currently leads in terms of market share, driven by strong investments in research and development, robust healthcare infrastructure, and high adoption rates of advanced healthcare technologies. Europe follows closely behind, with countries like Germany, France, and the UK at the forefront of mRNA vaccine development and distribution. In Asia, rapid advancements in healthcare technology and increasing government initiatives to promote vaccination programs are driving market growth. The Middle East and Africa region is witnessing a gradual uptake of mRNA vaccines, supported by improving healthcare facilities and awareness initiatives. Latin America is also showing promising growth potential, with countries like Brazil and Mexico investing in expanding their vaccine manufacturing capabilities to meet the growing demand for mRNA vaccines and therapeutics.
Global mRNA Vaccines and Therapeutics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global mRNA Vaccines and Therapeutics Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global mRNA Vaccines and Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Global mRNA Vaccines and Therapeutics Market - Industry Life Cycle |
3.4 Global mRNA Vaccines and Therapeutics Market - Porter's Five Forces |
3.5 Global mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.7 Global mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Therapeutic Type, 2021 & 2031F |
3.8 Global mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Global mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Delivery Method, 2021 & 2031F |
3.10 Global mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global mRNA Vaccines and Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global mRNA Vaccines and Therapeutics Market Trends |
6 Global mRNA Vaccines and Therapeutics Market, 2021 - 2031 |
6.1 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By COVID-19 Vaccine, 2021 - 2031 |
6.1.3 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Influenza Vaccine, 2021 - 2031 |
6.1.4 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Rabies Vaccine, 2021 - 2031 |
6.1.5 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Zika Virus Vaccine, 2021 - 2031 |
6.1.6 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By CMV Vaccine, 2021 - 2031 |
6.2 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Therapeutic Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Cancer Immunotherapy, 2021 - 2031 |
6.2.3 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Personalized Cancer Vaccine, 2021 - 2031 |
6.2.4 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Protein Replacement Therapy, 2021 - 2031 |
6.2.5 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Autoimmune Disease Treatment, 2021 - 2031 |
6.2.6 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By mRNA-Based Drug Delivery, 2021 - 2031 |
6.3 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Infectious Diseases, 2021 - 2031 |
6.3.3 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Oncology, 2021 - 2031 |
6.3.4 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Genetic Disorders, 2021 - 2031 |
6.3.5 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Neurological Disorders, 2021 - 2031 |
6.3.6 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031 |
6.4 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Delivery Method, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Intramuscular Injection, 2021 - 2031 |
6.4.3 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Subcutaneous Injection, 2021 - 2031 |
6.4.4 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Intradermal Injection, 2021 - 2031 |
6.4.5 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Intravenous Infusion, 2021 - 2031 |
6.4.6 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Oral Delivery, 2021 - 2031 |
6.5 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By End User, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.5.3 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.5.4 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Research Institutes, 2021 - 2031 |
6.5.5 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Biotechnology Firms, 2021 - 2031 |
6.5.6 Global mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031 |
7 North America mRNA Vaccines and Therapeutics Market, Overview & Analysis |
7.1 North America mRNA Vaccines and Therapeutics Market Revenues & Volume, 2021 - 2031 |
7.2 North America mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) mRNA Vaccines and Therapeutics Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada mRNA Vaccines and Therapeutics Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America mRNA Vaccines and Therapeutics Market, Revenues & Volume, 2021 - 2031 |
7.3 North America mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.4 North America mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Therapeutic Type, 2021 - 2031 |
7.5 North America mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.6 North America mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Delivery Method, 2021 - 2031 |
7.7 North America mRNA Vaccines and Therapeutics Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) mRNA Vaccines and Therapeutics Market, Overview & Analysis |
8.1 Latin America (LATAM) mRNA Vaccines and Therapeutics Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil mRNA Vaccines and Therapeutics Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico mRNA Vaccines and Therapeutics Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina mRNA Vaccines and Therapeutics Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM mRNA Vaccines and Therapeutics Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
8.4 Latin America (LATAM) mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Therapeutic Type, 2021 - 2031 |
8.5 Latin America (LATAM) mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
8.6 Latin America (LATAM) mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Delivery Method, 2021 - 2031 |
8.7 Latin America (LATAM) mRNA Vaccines and Therapeutics Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia mRNA Vaccines and Therapeutics Market, Overview & Analysis |
9.1 Asia mRNA Vaccines and Therapeutics Market Revenues & Volume, 2021 - 2031 |
9.2 Asia mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India mRNA Vaccines and Therapeutics Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China mRNA Vaccines and Therapeutics Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan mRNA Vaccines and Therapeutics Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia mRNA Vaccines and Therapeutics Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
9.4 Asia mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Therapeutic Type, 2021 - 2031 |
9.5 Asia mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
9.6 Asia mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Delivery Method, 2021 - 2031 |
9.7 Asia mRNA Vaccines and Therapeutics Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa mRNA Vaccines and Therapeutics Market, Overview & Analysis |
10.1 Africa mRNA Vaccines and Therapeutics Market Revenues & Volume, 2021 - 2031 |
10.2 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt mRNA Vaccines and Therapeutics Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria mRNA Vaccines and Therapeutics Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
10.4 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Therapeutic Type, 2021 - 2031 |
10.5 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
10.6 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Delivery Method, 2021 - 2031 |
10.7 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe mRNA Vaccines and Therapeutics Market, Overview & Analysis |
11.1 Europe mRNA Vaccines and Therapeutics Market Revenues & Volume, 2021 - 2031 |
11.2 Europe mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom mRNA Vaccines and Therapeutics Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany mRNA Vaccines and Therapeutics Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France mRNA Vaccines and Therapeutics Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe mRNA Vaccines and Therapeutics Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
11.4 Europe mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Therapeutic Type, 2021 - 2031 |
11.5 Europe mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
11.6 Europe mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Delivery Method, 2021 - 2031 |
11.7 Europe mRNA Vaccines and Therapeutics Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East mRNA Vaccines and Therapeutics Market, Overview & Analysis |
12.1 Middle East mRNA Vaccines and Therapeutics Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia mRNA Vaccines and Therapeutics Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE mRNA Vaccines and Therapeutics Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey mRNA Vaccines and Therapeutics Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
12.4 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Therapeutic Type, 2021 - 2031 |
12.5 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
12.6 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Delivery Method, 2021 - 2031 |
12.7 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global mRNA Vaccines and Therapeutics Market Key Performance Indicators |
14 Global mRNA Vaccines and Therapeutics Market - Export/Import By Countries Assessment |
15 Global mRNA Vaccines and Therapeutics Market - Opportunity Assessment |
15.1 Global mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
15.3 Global mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Therapeutic Type, 2021 & 2031F |
15.4 Global mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
15.5 Global mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Delivery Method, 2021 & 2031F |
15.6 Global mRNA Vaccines and Therapeutics Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global mRNA Vaccines and Therapeutics Market - Competitive Landscape |
16.1 Global mRNA Vaccines and Therapeutics Market Revenue Share, By Companies, 2024 |
16.2 Global mRNA Vaccines and Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |